Bridgeway Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Bridgeway Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$230K	Hold	61,800	–	–	﹤0.01%	1001
2025 Q4	$506K	Hold	61,800	–	–	0.01%	817
2025 Q3	$455K	Hold	61,800	–	–	0.01%	822
2025 Q2	$502K	Hold	61,800	–	–	0.01%	777
2025 Q1	$435K	Sell	61,800 -17,000	-22%	-$106K	0.01%	768
2024 Q4	$585K	Buy	78,800 +1,900	+2%	+$12.1K	0.01%	778
2024 Q3	$379K	Hold	76,900	–	–	0.01%	925
2024 Q2	$394K	Hold	76,900	–	–	0.01%	916
2024 Q1	$408K	Buy	+76,900	New	+$550K	0.01%	976
2023 Q1	–	Sell	-55,000	Closed	-$356K	–	1407
2022 Q4	$356K	Hold	55,000	–	–	0.01%	956
2022 Q3	$489K	Sell	55,000 -25,000	-31%	-$254K	0.01%	900
2022 Q2	$798K	Hold	80,000	–	–	0.02%	778
2022 Q1	$926K	Sell	80,000 -25,000	-24%	-$278K	0.02%	803
2021 Q4	$1.17M	Buy	+105,000	New	+$1.02M	0.02%	755
2020 Q4	–	Sell	-15,000	Closed	-$146K	–	1340
2020 Q3	$146K	Hold	15,000	–	–	﹤0.01%	1222
2020 Q2	$119K	Buy	+15,000	New	+$155K	﹤0.01%	1220
2019 Q1	–	Sell	-16,000	Closed	-$189K	–	1370
2018 Q4	$189K	Sell	16,000 -9,900	-38%	-$136K	﹤0.01%	1226
2018 Q3	$373K	Hold	25,900	–	–	﹤0.01%	1208
2018 Q2	$386K	Hold	25,900	–	–	﹤0.01%	1200
2018 Q1	$338K	Hold	25,900	–	–	﹤0.01%	1178
2017 Q4	$326K	Hold	25,900	–	–	﹤0.01%	1199
2017 Q3	$335K	Buy	+25,900	New	+$341K	﹤0.01%	1180
2016 Q2	–	Sell	-44,200	Closed	-$464K	–	1462
2016 Q1	$464K	Sell	44,200 -25,000	-36%	-$275K	0.01%	1090
2015 Q4	$819K	Hold	69,200	–	–	0.02%	845
2015 Q3	$808K	Hold	69,200	–	–	0.02%	824
2015 Q2	$999K	Sell	69,200 -20,000	-22%	-$289K	0.02%	789
2015 Q1	$1.24M	Sell	89,200 -16,500	-16%	-$228K	0.03%	701
2014 Q4	$1.46M	Hold	105,700	–	–	0.03%	636
2014 Q3	$1.29M	Sell	105,700 -130,900	-55%	-$1.63M	0.03%	649
2014 Q2	$2.96M	Buy	236,600 +130,900	+124%	+$1.54M	0.08%	370
2014 Q1	$1.18M	Sell	105,700 -11,900	-10%	-$131K	0.03%	691
2013 Q4	$1.43M	Sell	117,600 -74,100	-39%	-$885K	0.04%	609
2013 Q3	$2.34M	Sell	191,700 -164,500	-46%	-$2.3M	0.08%	351
2013 Q2	$4.71M	Buy	+356,200	New	+$4.93M	0.19%	92

Other funds holding LFCR

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return